123 related articles for article (PubMed ID: 2154381)
1. Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.
Milatovic D
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):33-5. PubMed ID: 2154381
[TBL] [Abstract][Full Text] [Related]
2. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Pascual A; López-López G; Aragón J; Perea EJ
Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
[TBL] [Abstract][Full Text] [Related]
3. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Paulsen P; Simon C; Peters O; Hedderich J; Heim P
Chemotherapy; 1992; 38(3):185-90. PubMed ID: 1324831
[TBL] [Abstract][Full Text] [Related]
4. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae.
Goldstein FW; Emirian MF; Coutrot A; Acar JF
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():25-8. PubMed ID: 2154434
[TBL] [Abstract][Full Text] [Related]
5. Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.
Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G
Chemotherapy; 1993; 39(1):48-54. PubMed ID: 8444060
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.
Pruul H; McDonald PJ
Antimicrob Agents Chemother; 1992 Jan; 36(1):10-6. PubMed ID: 1317141
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
Guggenbichler JP; Georgopoulos A; Scharrer P; Kobilansky C; Mühlbacher J; Georgopoulos M; Dierich MP
Infection; 1993; 21(4):259-61. PubMed ID: 8225634
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
9. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria.
Kitzis MD; Goldstein FW; Miégi M; Acar JF
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():15-8. PubMed ID: 2154432
[TBL] [Abstract][Full Text] [Related]
11. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP
Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs.
Ersoy B; Aktan B; Kilic K; Sakat MS; Sipal S
J Laryngol Otol; 2018 Jul; 132(7):579-583. PubMed ID: 29888693
[TBL] [Abstract][Full Text] [Related]
13. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo.
Retsema JA; Girard AE; Girard D; Milisen WB
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():83-9. PubMed ID: 2154442
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
Rolin O; Bouanchaud DH
Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Viluksela M; Vainio PJ; Tuominen RK
J Antimicrob Chemother; 1996 Sep; 38(3):465-73. PubMed ID: 8889721
[TBL] [Abstract][Full Text] [Related]
16. Phagocyte uptake and transport of azithromycin.
McDonald PJ; Pruul H
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):828-33. PubMed ID: 1662626
[TBL] [Abstract][Full Text] [Related]
17. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
18. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
19. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci.
Chang JC; Hsueh PR; Young C
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):276-84. PubMed ID: 1342645
[TBL] [Abstract][Full Text] [Related]
20. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
